Randomized Controlled Trial of Occupational Performance Coaching for Adults With Multiple Sclerosis

被引:1
|
作者
Kessler, Dorothy [1 ]
Franz, Martina [1 ]
Malakouti, Niloufar [1 ,3 ]
Rajachandrakumar, Roshanth [1 ,4 ]
Baharnoori, Moogeh [2 ]
Finlayson, Marcia [1 ]
机构
[1] Queens Univ, Sch Rehabil Therapy, Kingston, ON, Canada
[2] Queens Univ, Dept Med, Div Neurol, Kingston, ON, Canada
[3] Thomas Jefferson Univ, Philadelphia, PA USA
[4] Queens Univ, Canadian Canc Trials Grp, Kingston, ON, Canada
来源
关键词
Coaching; Functional status; Multiple sclerosis; Occupational therapy; Rehabilitation; COGNITIVE-STRATEGY; PARTICIPATION; IMPACT; PEOPLE; ORIENTATION; RESILIENCE; VALIDITY; HEALTH; RESPONSIVENESS; QUESTIONNAIRE;
D O I
10.1016/j.apmr.2024.05.022
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective: To determine if the receipt of occupational performance coaching (OPC) by adults living with multiple sclerosis (MS) improves participants' satisfaction with performance in daily activities (primary outcome); improves perceived performance in daily activities, resilience, autonomy, and participation; and reduces illness intrusiveness and effect of MS (secondary outcomes). Design: Two-group randomized clinical trial with a waitlist control. Setting: Community. Participants: Convenience sample of adults with MS were recruited through a research registry. Eighty-three individuals were approached; 35 were assessed for eligibility and 31 were enrolled and 30 completed baseline assessment (Final sample size, N=30). Participants were Englishspeaking, were without serious cognitive impairment or severe depression, and were not receiving other coaching interventions. Interventions: Six telephone sessions of OPC were delivered by a trained facilitator over 10 weeks. Initial sessions focused on goal setting, prioritization, and action planning. Subsequent sessions involved goal and action plan review, discussion of facilitators and barriers, and goal and plan refinement. Main Outcome Measures: Primary outcome was participants' satisfaction with performance in daily activities, as measured by the Canadian Occupational Performance Measure (COPM). Secondary outcome measures included the COPM performance rating, Connor-Davidson Resilience Scale, Impact on Participation and Autonomy Questionnaire, Adapted Illness Intrusiveness Rating Scale, and MS Impact Scale. Measures were administered by a blinded assessor at baseline, 10 weeks, and 2 months. Results: Participants in the intervention and waitlist control groups were equivalent on demographic and outcome measures at baseline. At 10 weeks, the intervention group had significantly higher COPM ratings for both satisfaction (P<.001) and performance (P=.002). No other outcomes were significantly different. For the intervention group, the benefits of OPC were maintained at 2 months. Conclusions: OPC led to improved satisfaction with performance and performance in daily activities. Future research with a larger sample is needed to determine other effects and who benefits most from OPC. Archives of Physical Medicine and Rehabilitation 2024;105:1649-56 (c) 2024 by the American Congress of Rehabilitation Medicine.
引用
收藏
页码:1649 / 1656
页数:8
相关论文
共 50 条
  • [31] Evaluating occupational performance coaching to support fatigue management for people with multiple sclerosis: A feasibility study
    Askari, Sorayya
    Kessler, Dorothy
    Smyth, Penelope
    Finlayson, Marcia
    CLINICAL REHABILITATION, 2022, 36 (09) : 1244 - 1256
  • [32] Occupational therapy in multiple system atrophy: A pilot randomized controlled trial
    Jain, S
    Dawson, J
    Quinn, NP
    Playford, ED
    MOVEMENT DISORDERS, 2004, 19 (11) : 1360 - 1364
  • [33] Online occupational therapy in the caregivers of people with Multiple sclerosis: a randomized control trial
    Motaharinezhad, Fatemeh
    Ghahari, Setareh
    Hassani Mehraban, Afsoon
    Lajevardi, Laleh
    Binesh, Maryam
    DISABILITY AND REHABILITATION, 2024, 46 (16) : 3602 - 3608
  • [34] The effectiveness of a self-management occupational therapy intervention on activity performance in individuals with multiple sclerosis-related fatigue: a randomized-controlled trial
    Kos, Daphne
    Duportail, Marijke
    Meirte, Jill
    Meeus, Mira
    D'hooghe, Marie B.
    Nagels, Guy
    Willekens, Barbara
    Meurrens, Tom
    Ilsbroukx, Stephan
    Nijs, Jo
    INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH, 2016, 39 (03) : 255 - 262
  • [35] An individual self-management occupational therapy programme to optimize the performance and satisfaction of relevant daily activities in people with multiple sclerosis: a randomized controlled trial
    Kos, D.
    Meirte, J.
    Van Cauwenbergh, D.
    Meeus, M.
    Nagels, G.
    D'hooghe, M. B.
    Willekens, B.
    Duportail, M.
    Hellinckx, P.
    Eelen, P.
    Meurrens, T.
    Nijs, J.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 310 - 311
  • [36] Occupational therapy for independent-living older adults - A randomized controlled trial
    Clark, F
    Azen, SP
    Zemke, R
    Jackson, J
    Carlson, M
    Mandel, D
    Hay, J
    Josephson, K
    Cherry, B
    Hessel, C
    Palmer, J
    Lipson, L
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (16): : 1321 - 1326
  • [37] Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis
    Panitch, HS
    Thisted, RA
    Smith, RA
    Wynn, DR
    Wymer, JP
    Achiron, A
    Vollmer, TL
    Mandler, RN
    Dietrich, DW
    Fletcher, M
    Pope, LE
    Berg, JE
    Miller, A
    ANNALS OF NEUROLOGY, 2006, 59 (05) : 780 - 787
  • [38] A Randomized Controlled Trial of Neuroprotection with Lamotrigine in Secondary Progressive Multiple Sclerosis
    Kapoor, Raju
    Furby, Julian
    Hayton, Thomas
    Smith, Kenneth
    Altmann, Daniel
    Brenner, Robert
    Chataway, Jeremy
    Hughes, Richard
    Miller, David
    NEUROLOGY, 2010, 74 (09) : A193 - A193
  • [39] A randomized controlled trial of a cognitive rehabilitation intervention for persons with multiple sclerosis
    Stuifbergen, Alexa K.
    Becker, Heather
    Perez, Frank
    Morison, Janet
    Kullberg, Vicki
    Todd, Ana
    CLINICAL REHABILITATION, 2012, 26 (10) : 882 - 893
  • [40] A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
    Polman, CH
    O'Connor, PW
    Havrdova, E
    Hutchinson, M
    Kappos, L
    Miller, DH
    Phillips, JT
    Lublin, FD
    Giovannoni, G
    Wajgt, A
    Toal, M
    Lynn, F
    Panzara, MA
    Sandrock, AW
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (09): : 899 - 910